Mitchell E. Geffner, MD

The Saban Research Institute of Children’s Hospital Los Angeles and Keck School of Medicine of the University of Southern California
Los Angeles, California, United States

Disclosure information not submitted.

Presentation(s):

• SUN-465 - Long-Term Crinecerfont Enables Sustained Decreases in Glucocorticoid Doses and Improves Clinical Outcomes in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: 2-Year Results from Cahtalyst™ Pediatric

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT